Default: Neurotherapeutics

ISSN: 1933-7213

Journal Home

Journal Guideline

Neurotherapeutics Q1 Unclaimed

Springer New York United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Neurotherapeutics is a journal indexed in SJR in Pharmacology and Neurology (clinical) with an H index of 114. It has a price of 3690 €. It has an SJR impact factor of 2,496 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,496.

Neurotherapeutics focuses its scope in these topics and keywords: autism, model, microglial, micefluidbased, macrophages, loss, longitudinal, lateral, kindled, monocytederived, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Neurotherapeutics

2,496

SJR Impact factor

114

H Index

191

Total Docs (Last Year)

296

Total Docs (3 years)

16419

Total Refs

2063

Total Cites (3 years)

266

Citable Docs (3 years)

6,31

Cites/Doc (2 years)

85,96

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


autism, model, microglial, micefluidbased, macrophages, loss, longitudinal, lateral, kindled, monocytederived, naïve, pluripotent, orbitofrontal, neurotrophin, neuropeptideloaded, neuronal, neurologic, neoplasiaa, nanoparticlesmicroglia, invasion, intranasal, injuryimmune, immunomodulatory, baclofen, biomarkers, brain, cell, cocaineexposed, cord, delivery, directions, eker, expectancies, experience, extensive, future, historical, induced,



Best articles by citations

Stuck in the Mire

View more

The treatment of movement disorders by deep brain stimulation

View more

Interleukin-1beta Causes Fluoxetine Resistance in an Animal Model of Epilepsy-Associated Depression

View more

Modulation of Aversive Memory by Adult Hippocampal Neurogenesis

View more

Approaching a new age in Duchenne muscular dystrophy treatment

View more

MRI in multiple sclerosis: What's inside the toolbox?

View more

Commentary: A skeptical view of experimental gene therapy to block epileptogenesis

View more

Transplantation of GABA-producing cells for seizure control in models of temporal lobe epilepsy

View more

Progress in Cell Grafting Therapy for Temporal Lobe Epilepsy

View more

Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury

View more

Assessment of Motor Units in Neuromuscular Disease

View more

Neuropeptide Y overexpression using recombinant adenoassociated viral vectors

View more
SHOW MORE ARTICLES

Deep brain stimulation for psychiatric disorders

View more

Repetitive Transcranial Magnetic Stimulation Alleviates Neurological Deficits After Cerebral Ischemia Through Interaction Between RACK1 and BDNF exon IV by the Phosphorylation-Dependent Factor MeCP2

View more

The hereditary inclusion body myopathy enigma and its future therapy

View more

Immunosuppressive agents in multiple sclerosis

View more

A Systems Approach to Drug Discovery in Alzheimer's Disease

View more

Comparative Analysis of the Treatment of Chronic Antipsychotic Drugs on Epileptic Susceptibility in Genetically Epilepsy-prone Rats

View more

Calpain as a therapeutic target in traumatic brain injury

View more

Leveraging Optogenetic-Based Neurovascular Circuit Characterization for Repair

View more

New treatments for neuromuscular disease: Optimism and obstacles

View more

Neuroimmunotherapeutics comes of age

View more

Erratum to: Remarkable Phenytoin Sensitivity in 4 Children with SCN8A-related Epilepsy: A Molecular Neuropharmacological Approach

View more

The ketogenic diet: Proposed mechanisms of action

View more

FAQS